RMMS was recognized in the 2020 edition of Chambers USA: America's Leading Lawyers in Business, as a leading Intellectual Property firm, and founding partner William Rakoczy was also distinguished as a leader in the field. While RMMS was already listed in the Chambers USA guide, the firm and Mr. Rakoczy were both promoted for 2020, in recognition of the firm's accomplishments over the prior year.
Specifically, RMMS has been promoted to a “Band 3” ranking in the Illinois – Intellectual Property guide. Mr. Rakoczy was promoted to Band 2 on the individual rankings table.
In connection with the firm’s work, Chambers USA recognizes the RMMS as a:
Boutique firm much admired for its artful representation of generic pharmaceutical manufacturers in complex ANDA litigation. Other areas of strength include freedom-to-operate searches and licensing and collaboration agreements. Increasing bench strength sees it offer wider expertise beyond its traditional generics client base, bolstering its handling of brand mandates.
As part of its research, Chambers interviews lawyers and clients. One client praised the RMMS team, noting that “[t]he team's work is exceptionally thorough and the insights it provides are very helpful.”
Headquartered in Chicago, RMMS is a full-service litigation and intellectual property law firm with over 30 attorneys devoted exclusively to the pharmaceutical industry, including specialty practice in the field of patent and regulatory counseling and litigation under the Hatch-Waxman Act, the Medicare Prescription Drug, Improvement, and Modernization Act (MMA), and the Biologics Price Competition and Innovation Act (BPCIA).